Geriatric practices use TITN to capture a quantified electrophysiological cognitive baseline, so a later study has something to compare against on the same numbers, ordered when clinically indicated. WAVi records EEG and event-related potentials in about twenty minutes.
Because a brief screen gives you a score at one visit, and a repeatable protocol gives you a trend. WAVi quantifies EEG rhythms and the P300 response against an age-matched normative database, so a baseline and a retest compare on the same numbers. It aids diagnosis alongside history, exam, labs, and imaging; it does not replace them.
WAVi runs in about twenty minutes with a trained tech, capturing resting EEG and the P300 event-related potential. The same protocol at each repeat study turns a subjective impression into a side-by-side comparison the patient can follow.
TM-Flow adds heart-rate variability and vascular indices chairside, which is relevant when orthostatic symptoms or falls are part of the picture. The autonomic data is one input in a broader evaluation, not a falls-risk verdict.
BMTG combines the WAVi and TM-Flow data into a Cognitive Function Report interpreted by board-certified neurologists and returned through a HIPAA-compliant portal, standard turnaround inside 7 business days.
WAVi and TM-Flow. WAVi is FDA 510(k) cleared (K213900) to aid in diagnosis, not to diagnose any condition on its own, recording EEG, event-related potentials, and quantitative analysis in about twenty minutes. TM-Flow is built on three FDA 510(k)-cleared modules (K173696, K152216, K200141) for autonomic, sudomotor, and vascular measures. Provider-ordered genetic panels run through PreCheckHealth when a specific question is on the table. Coverage is decided by your payer on the documented indication.

Quantified EEG and event-related potentials to aid cognitive assessment, with baseline-to-retest tracking. On the Medicare cognitive care plan pathway, the WAVi assessment pairs with the cognitive care plan at the same visit.

Autonomic function, sudomotor, and ankle-brachial testing in one visit, relevant in geriatric patients with orthostatic changes, autonomic dysfunction, or peripheral vascular concerns. Built on three FDA 510(k)-cleared modules.

Provider-ordered panels through PreCheckHealth: PharmacoCheck+ for drug-metabolizing enzyme variants in a patient on several medications, and the Comprehensive Neurogenetic Panel (203 genes) when family history raises an inherited question. Run by a CLIA-certified lab. Clinical, not a consumer test.
BMTG is TITN's interpretation arm. You order the test; a board-certified neurologist reads it and the report comes back to you. The Cognitive Function Report is your clinical read for cognitive and MCI assessment in geriatric patients; Case Reviews give your most complex cases a second neurologist read, with you as the ordering provider throughout.
Read by a BMTG board-certified neurologist, or by your own neurologist using our templates, returned through our HIPAA portal inside 7 business days.
When a presentation crosses systems, BMTG Case Reviews add a second board-certified neurologist read on the WAVi and autonomic data, feeding both your clinical record and the report.
BMTG is TITN's interpretation arm, and the ordering provider is the customer throughout. The report does not diagnose; it documents measured data a clinician interprets.
The reason clinics keep the equipment running is the wrap around it. Here is what comes with a geriatric placement, and how we build the practice around it.
Live sessions, recorded walkthroughs, and interpretation guides. Your team runs real tests; a TITN clinical trainer reviews the reports with them until interpretation sticks.
The coverage checklist per device, your contractor's policy read with you, documentation templates, and your certified coder in the loop.
On-site or remote setup, calibration, and staff onboarding. A named TITN contact, not a ticket queue.
Flexible financing structures built around your expected reimbursement timeline. Multiple lender and lease pathways with transparent ROI modeling.
Workflow design, reimbursement coaching, protocol setup. Practical, billable advice.
Mobile-first WordPress sites with scheduling baked in. The same aesthetic as this one.
AI-generated brand films or full productions filmed at your clinic. Edited, scored, finished.
Local SEO, structured data, and CRM lead-intake that routes new-patient inquiries automatically.
What a geriatric practice asks before ordering.
WAVi and TM-Flow, ordered when clinically indicated. WAVi is FDA 510(k) cleared (K213900) to aid in diagnosis, not to diagnose any condition on its own, and records EEG, event-related potentials including P300, and quantitative analysis against an age-matched normative database in about twenty minutes. TM-Flow, built on three FDA 510(k)-cleared modules (K173696, K152216, K200141), adds autonomic, sudomotor, and vascular measures chairside. Provider-ordered genetic panels run through PreCheckHealth when a specific question is on the table.
Coverage and coding are decided by your payer on the documented indication, and policies differ by Medicare contractor and commercial plan. Confirm every code with your own contractor and certified coder before you bill. TITN sets the workflow to documented medical necessity: tests are ordered when clinically indicated, never on a schedule and never on every patient, and the documentation is built to support the claim.
The established brief screens used in primary and geriatric care are the MMSE, Mini-Cog, MoCA, and SLUMS, and a formal cognitive assessment sits alongside history, exam, labs, and imaging rather than in place of them. WAVi is an added electrophysiological data point next to those screens, not a substitute for any of them. Your clinician interprets the result and decides what follows.
The research is promising rather than settled. Published work reports that P300 latency and amplitude changes correlate with mild cognitive impairment and improve discrimination when combined with other markers, but no guideline positions it as a stand-alone diagnostic. WAVi documents measured brain activity to aid in diagnosis; it does not detect or diagnose mild cognitive impairment, and the clinician interprets every read.
No. A brief EEG and P300-based assessment is not equivalent to comprehensive neuropsychological testing and does not replace it. The Cognitive Function Report is a clinical adjunct that documents measured brain and autonomic data for the ordering provider to interpret. When a fuller picture is needed, formal neuropsychological evaluation, imaging, or referral remain the standard-of-care path, decided by your clinical judgment.
WAVi takes about twenty minutes and is run by a trained technician, not the physician. TM-Flow adds about ten minutes chairside. Data goes to TITN's HIPAA-compliant portal, and BMTG's board-certified neurologists interpret the combined result as a Cognitive Function Report, standard turnaround inside 7 business days. Your own neurologist can do the read instead, using BMTG templates.
That is your call. The Cognitive Function Report documents measured data and aids diagnosis; it does not dictate management. An abnormal or borderline result would ordinarily prompt standard-of-care follow-up, which may include further cognitive or neuropsychological testing, imaging, medication review, or referral, decided by the ordering clinician on the whole clinical picture. The retest, run on the same protocol, documents what changed.
They are different deliverables for different contexts. The Cognitive Function Report is BMTG's clinical-track cognitive assessment, combining WAVi and TM-Flow data for the ordering provider, and it is the right report for geriatric cognitive care. The Post-Injury Brain Function Report is the med-legal, WAVi-only deliverable for personal-injury cases, signed by a board-certified neurologist. Neither report diagnoses a condition; each documents measured data a clinician interprets.
In two specific situations, not as a screen. PharmacoCheck+ reports drug-metabolizing enzyme variants for a patient on several medications, as one input the prescriber weighs against published gene-drug guidance. The Comprehensive Neurogenetic Panel covers 203 genes and is ordered when family history raises an inherited question. The ACMG and NSGC joint guideline supports testing in families with a known inherited pattern, under genetic counseling, and advises against susceptibility testing in people without symptoms; TITN positions the panel the same way. Both are provider-ordered, buccal-swab panels run by a CLIA-certified lab and billed by PreCheckHealth, with genetic counseling available through the lab.
A short call covers devices, reimbursement, and onboarding for your workflow. No commitment beyond the first conversation.
Roberto or Weston takes the call personally. We walk you through WAVi, TM-Flow, the Medicare cognitive care plan pathway, the MCI report layer, and the billing path for geriatrics.
Pick a time →A de-identified, watermarked sample of the neurologist-read cognitive report your practice would receive.
Open the sample →FDA 510(k) clearances verified in the openFDA device database. Coverage policies are read in the CMS Medicare Coverage Database. Coverage and payment are decided by each payer on the documented indication; nothing on this site is a guarantee of payment.